Transplantation and Cellular Therapy 2021: Analysis of a study investigating CAR T therapy axicabtagene ciloleucel for treatment of relapsed indolent lymphomas.
Home / Resource Library / CAR T Cell Therapy Shows Benefits in Patients With R/R Indolent Non-Hodgkin Lymphoma